Navidea Biopharmaceuticals, Inc.

NAVBDelisted Jan 16, 2024

Industry: In Vitro & In Vivo Diagnostic Substances
SEC CIK: 0000810509

SEC filings (opens in a new tab)

Navidea Biopharmaceuticals, Inc. was delisted on Jan 16, 2024; its insiders filed their last Form 4 on Dec 5, 2023; 24 institutions reported holding it in 13F filings for Q3 2023, worth $225.8K in total; no superinvestor held it.

Superinvestors holding NAVB, Q3 2023

See all superinvestors

No superinvestor reported holding NAVB in Q3 2023.